Atrium ClearWay RX    
Login  


ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions
Imaging
Complex Coronary Interventions
Chronic Total Occlusion
Drug-Eluting Stents
Emerging Devices & Innovative Therapies
Nurse & Tech Corner
Peripheral Interventions
Vulnerable Plaque
Workshop with the FDA


 TCT (Transcatheter Cardiovascular Therapeutics) -> TCT 2009

10/5/2009
JP Morgan Survey- What the Docs are Saying Post TCT
JP Morgan

10/5/2009
European vs. USA Guidelines-Similarities and Differences
Prof. Dr. Sigmund Silber FACC, FESC

9/28/2009
Non-US Physician - Scientist Perspectives: Device Regulation and Approvals
Prof. Dr. Sigmund Silber FACC, FESC

9/28/2009
Summarizing the B.Braun PEPCAD Coronary Paclitaxel-Eluting Balloon Clinical Studies
Martin Unverdorben

9/28/2009
ESC Give STEMI Aspiration a IIB Indication: The Data is Not Definitive!
Prof. Dr. Sigmund Silber FACC, FESC

9/28/2009
FAUST Trial
Arnold Seto, MD, MPA

9/28/2009
BCIS-1
Simon Redwood, MD

9/25/2009
Horizons AMI
Gregg W. Stone MD

9/25/2009
Nordic-Baltic Bifurcation Study III
Matti Niemela, et al.

9/25/2009
The Femoral Arterial Access with Ultrasound Trial (FAUST)
Arnold Seto, MD, MPA

9/24/2009
HDL Therapy Via Plasmapheresis
Ron Waksman, MD

9/24/2009
Results from the TRITON-TIMI 38 Trial
David J. Cohen, MD

9/24/2009
The PROSPECT Trial
Gregg W. Stone, MD

9/24/2009
PLATO Invasive Trial
Cannon, MD

9/24/2009
CURRENT-STEMI PCI
Shamir R. Mehta, MD

9/24/2009
CHARISMA Genomics
Deepak L. Bhatt MD, MPH

9/24/2009
The COGENT Trial
Deepak L. Bhatt MD, MPH

9/24/2009
Summarizing the B.Braun PEPCAD Coronary Paclitaxel-Eluting Balloon Clinical Studies
Martin Unverdorben, MD

9/24/2009
XIENCE V EXCEED and National Cardiovascular Data Registry (NCDR)
John McPherson, MD

9/24/2009
COMPARE Trial
Peter Smits, MD

9/24/2009
FAME Late Breaking Trial
Nico H.J.Pijls, MD, PhD

9/23/2009
SPIRIT IV One-Year Clinical Results
Gregg W. Stone, MD

9/23/2009
SIRTAX-LATE 5-Year Clinical and Angiographic Follow-up
Lorenz Räber, MD

9/23/2009
LEADERS 2-Year Clinical Follow-Up
Volker Klauss, MD

9/23/2009
FAME 2-Year Follow-Up
William F. Fearon, MD

9/23/2009
ISAR-DESIRE 2
Robert A. Byrne, MD

9/23/2009
Predictors and Causes of Death in Patients with Severe Symptomatic Aortic Stenosis
Itsik Ben Dor, MD

9/23/2009
The Global Landscape for DES Utilization
Sigmund Silber, MD, PhD

9/22/2009
SPIRIT III 3-Year Results
Gregg W. Stone, MD

9/21/2009
3D-IVUS Analysis From the RESOLUTE Trial
Katsuhisa Wasedaa, et al.

9/21/2009
Predictors of Binary In-segment Restenosis in Patients Treated with Zotarolimus-Eluting Stent
Eugenia Nikolsky, et al.

9/21/2009
12-month Outcomes from the E-Five Registry
Ajay K. Jain MD MRCP

9/21/2009
BRANCH Early Clinical Experience
Ian T. Meredith, MD

9/21/2009
Three Year Follow-up with New Zotarolimus-eluting Stent Endeavor Resolute
Ian T. Meredith, et al.

















Copyright © 2010, CRTONLINE - About / Contact Us. All rights reserved.Privacy Policy
Powered by Multiweb